chronic blockade of the dopamine ( da ) d2 receptor by repeated systemic administration of the butyrophenone neuroleptic , haloperidol ( hal ) , is known to lead to a decrease in levels of the neuroactive peptide , substance p ( sp ) , in the rat striatum and substantia nigra ( sn ) .
C0040615
neuroleptic
C0018546
haloperidol